Group One Trading’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11K | Buy |
+3,596
| New | +$14.3K | ﹤0.01% | 6338 |
|
|
2025
Q4 | – | Sell |
-133,701
| Closed | -$520K | – | 8732 |
|
|
2025
Q3 | $432K | Buy |
133,701
+85,476
| +177% | +$321K | ﹤0.01% | 3845 |
|
|
2025
Q2 | $139K | Buy |
48,225
+47,100
| +4,187% | +$109K | ﹤0.01% | 4679 |
|
|
2025
Q1 | $2.42K | Sell |
1,125
-12,228
| -92% | -$38.6K | ﹤0.01% | 6942 |
|
|
2024
Q4 | $51.7K | Buy |
13,353
+9,273
| +227% | +$61.2K | ﹤0.01% | 5032 |
|
|
2024
Q3 | $26.7K | Buy |
+4,080
| New | +$32.8K | ﹤0.01% | 5070 |
|
|
2024
Q2 | – | Sell |
-8,638
| Closed | -$66.2K | – | 7159 |
|
|
2024
Q1 | $65.6K | Buy |
+8,638
| New | +$67.3K | ﹤0.01% | 4487 |
|
|
2023
Q3 | – | Sell |
-500
| Closed | -$1.89K | – | 8003 |
|
|
2023
Q2 | $1.56K | Buy |
+500
| New | +$2.04K | ﹤0.01% | 7160 |
|
|
2021
Q4 | – | Sell |
-1,000
| Closed | -$12K | – | 8570 |
|
|
2021
Q3 | $12K | Buy |
+1,000
| New | +$12K | ﹤0.01% | 7423 |
|
|
2021
Q2 | – | Sell |
-416
| Closed | -$4.7K | – | 8371 |
|
|
2021
Q1 | $6K | Hold |
416
| – | – | ﹤0.01% | 7202 |
|
|
2020
Q4 | $9K | Hold |
416
| – | – | ﹤0.01% | 5826 |
|
|
2020
Q3 | $6K | Hold |
416
| – | – | ﹤0.01% | 5580 |
|
|
2020
Q2 | $5K | Buy |
416
+391
| +1,564% | +$4.55K | ﹤0.01% | 5367 |
|
|
2020
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 5528 |
|
|
2019
Q4 | $0 | Buy |
+25
| New | +$239 | ﹤0.01% | 5393 |
|
|
2019
Q3 | – | Sell |
-117
| Closed | -$2K | – | 5368 |
|
|
2019
Q2 | $2K | Sell |
117
-306
| -72% | -$8.15K | ﹤0.01% | 4760 |
|
|
2019
Q1 | $14K | Buy |
+423
| New | +$21.7K | ﹤0.01% | 4156 |
|
|
2018
Q3 | – | Sell |
-250
| Closed | -$31K | – | 5418 |
|
|
2018
Q2 | $31K | Buy |
250
+216
| +635% | +$18.3K | ﹤0.01% | 4198 |
|
|
2018
Q1 | $3K | Sell |
34
-285
| -89% | -$24.2K | ﹤0.01% | 4593 |
|
|
2017
Q4 | $18K | Buy |
+319
| New | +$14.4K | ﹤0.01% | 4184 |
|
|
2017
Q3 | – | Sell |
-402
| Closed | -$16.7K | – | 5004 |
|
|
2017
Q2 | $17K | Buy |
402
+181
| +82% | +$9.26K | ﹤0.01% | 4012 |
|
|
2017
Q1 | $12K | Sell |
221
-1,339
| -86% | -$66.5K | ﹤0.01% | 4066 |
|
|
2016
Q4 | $60K | Sell |
1,560
-250
| -14% | -$10.1K | ﹤0.01% | 3156 |
|
|
2016
Q3 | $72K | Buy |
1,810
+1,798
| +14,983% | +$81.7K | ﹤0.01% | 3127 |
|
|
2016
Q2 | $1K | Sell |
12
-251
| -95% | -$19.8K | ﹤0.01% | 4508 |
|
|
2016
Q1 | $21K | Sell |
263
-463
| -64% | -$36.6K | ﹤0.01% | 3718 |
|
|
2015
Q4 | $55K | Buy |
726
+20
| +3% | +$3.21K | ﹤0.01% | 3349 |
|
|
2015
Q3 | $271K | Buy |
+706
| New | +$318K | ﹤0.01% | 2271 |
|
Other funds holding LRMR
DM
BOCH
DCM
DCM
RI
DCM
Group One Trading's LRMR Position: Q2 2026 in Review
Group One Trading opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 3,596 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #6338 among its holdings. This is a return to the name: Group One Trading previously reported a position in LRMR as recently as Q3 2025.
Group One Trading first reported a position in LRMR in Q3 2015 and has held it in 28 quarters since. The position peaked at $432K in Q3 2025. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.
- Group One Trading held 3,596 shares of Larimar Therapeutics worth $11K as of Q2 2026.
- Larimar Therapeutics was a new Group One Trading position in Q2 2026.
- Larimar Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6338 holding.
- Group One Trading first reported a position in Larimar Therapeutics in Q3 2015 and has held it in 28 quarters since.
- Group One Trading's Larimar Therapeutics position peaked at $432K in Q3 2025.
- 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.